Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

スポンサーリンク

概要

• 論文の詳細を見る
• 2005-02-01

著者

• Yatsuhashi Hiroshi

  Institute For Clinical Research Nagasaki Chuo National Hospital

• IDE Tatsuya

  Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine

• FUJIYAMA Shigetoshi

  Department of Gastroenterology and Hepatology, NTT West Kyusyu Hospital

• Ide Tatsuya

  久留米大学 医学部免疫学講座

• Ide T

  Department Of Second Internal Medicine Kurume University School Of Medicine

• Ide Tatsuya

  Second Department Of Internal Medicine Kurume University School Of Medicine

• Ide Tatsuya

  久留米大学 医学部内科学第二

• Sakata M

  Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine

• Sata Michio

  久留米大学 医学部消化器外科

• SATA Michio

  Second Department of Internal Medicine, Kurume University

• Ide Tatsuya

  久留米大学 医学部消化器内科

• Ide Tatsuya

  Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine

• Ide Tatsuya

  The Second Department Of Medicine Kurume University School Of Medicine

• Ide Tatsuya

  2nd Department Of Internal Medicine Kurume University School Of Medicine

• Ide Tatsuya

  Kurume Univ. School Of Medicine Fukuoka Jpn

• WATANABE Hiroshi

  Third Department of Medicine, Fukuoka University School of Medicine

• Sata Michio

  久留米大学 医学部消化器内科部門

• Ide T

  Second Department Of Internal Medicine Kurume University School Of Medicine

• Iwao Tadashi

  Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine

• Ikeda Masafumi

  Department Of Agricultural Chemistry Kinki University

• Ikeda Masafumi

  Department Of Gastroenterology And Hepatology Graduate School Of Medical Sciences Kumamoto Universit

• Sata Michio

  Second Department Of Internal Medicine Kurume University School Of Medicine

• TANAKA MOTOHIKO

  Department of Gastroenterology and Hepatology, NTT West Kyushu General Hospital

• Tanaka Motohiko

  Department Of Gastroenterology And Hepatology Ntt West Kyushu General Hospital

• Murashima S

  Second Department Of Internal Medicine Kurume University School Of Medicine

• Sata Michio

  Second Dep. Of Internal Medicine Kurume Univ. School Of Medicine

• Yatsuhashi Hiroshi

  Institute For Clinical Research National Nagasaki Medical Center

• Tanaka Motohiko

  Department Of Gastroenterology And Hepatology Graduate School Of Medical Sciences Kumamoto Universit

• Fujiyama Shigetoshi

  Department Of Gastroenterology And Hepatology Ntt West Kyusyu Hospital

• Fujiyama Shigetoshi

  Department Of Gastroenterology And Hepatology Graduate School Of Medical Sciences Kumamoto Universit

• Watanabe Hiroshi

  Department Of Hepatology Japanese Red Cross Fukuoka Hospital

関連論文

• Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
• Human primary cultured hepatic stellate cells can be cryopreserved
• High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
• Case-control study for the identification of virological factors associated with fulminant hepatitis B
• Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
• Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
• Periostin and bone marrow fibrosis
• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Keratin inclusions alter cytosolic protein localization in hepatocytes
• Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
• Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
• New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
• Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
• Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
• Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice
• A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
• Angiogenic cell therapy for hepatic fibrosis
• Timing of interferon therapy and sources of infection in patients with acute hepatitis C
• Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
• A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
• A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
• Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
• Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
• Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
• Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C
• Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
• Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
• Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets
• High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
• Systemic Sclerosis Associated with Diabetes Insipidus
• Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
• ENDOSCOPIC RETRIEVAL OF MIGRATED PLASTIC STENT INTO BILE DUCT OR PANCREATIC PSEUDOCYST
• Immunoregulatory cytokines and intestinal inflammation
• Intestinal microflora as a therapeutic target in inflammatory bowel disease
• Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
• Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
• Cytomegalovirus Pneumonitis Presenting Small Nodular Opacities
• Propranolol ameliorates thrombocytopenia in patients with cirrhosis
• Upright posture blunts postprandial splanchnic hyperemia in patients with cirrhosis and portal hypertension
• Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment
• Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC
• GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
• Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
• Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
• OVEREXPRESSION OF MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE (MT1-MMP), MATRIX METALLOPRATEINASE-2 (MMP-2) IS ASSOCIATED WITH TUMOR DEVELOPMENT IN HEPATOCELLULAR CARCINOMA (HCC).
• Two-year follow-up study after treatment with lamivudine for chronic hepatitis B : seven cases reported
• Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif)
• Erythropoietic protoporphyria with fatal liver failure
• Intracellular traffic of asialoglycoproteins depends on vacuolar pH in polarized isolated rat hepatocyte couplets
• Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
• Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
• In Vitro Study of Neutrophil Apoptosis in Liver Cirrhosis
• Involvement of GBV-C/HGV in liver diseases in Japan
• High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
• Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes
• Hepatitis B virus of genotype C persistence after recovery from acute hepatitis B virus infection in Japan
• Detection of HBV RNA in peripheral blood mononuclear cells patients with and without HBsAg by reverse transcription polymerase chain reaction
• Analysis of α-fetprotein mRNA in peripheral blood: detection and semi-quantitation by reverse transcription polymerase chain reaction
• GB virus C/hepatitis G virus in Japanese patients with sporadic acute non A-E hepatitis
• Correlation between serum and liver tissue HCV-RNA levels in patients with chronic hepatitis C
• Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
• Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
• Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
• Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
• Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
• Long-term improvement of hepatic fibrosis in chronic hepatitis C treated with interferon-α
• Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells
• Functional liver imaging with asialoglycoprotein receptors and serum hyaluronate in a patient with amyloidosis
• Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method
• Analysis of serum hepatitis A virus antibody response in different courses of hepatitis A virus infection
• A pilot study of natural interferon γ therapy for chronic hepatitis C
• Liver-Associated Natural Killer Activity in Cirrhotic Rats
• Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
• Sequence Variation of the Hypervariable Region in HCV Carriers with Normal ALT Levels:A Comparison with Symptomatic Carriers
• High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection
• Natural disappearance of serum HCV RNA: prospective study in a hyperendemic area
• Controlled release of simvastatin acid using cyclodextrin inclusion system
• Association of HLA-DRB1 0803 and 1602 with the susceptibility to primary biliary cirrhosis
• Secretory IgA anti-HAV in bile of hepatitis A patients
• Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B
• Secretory IgA anti-HAV in saliva of hepatitis A patients
• Decreased regional cerebral blood flow during interferon therapy
• Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
• Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
• Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
• Second generation amplicor-HCV monitor assay : clinical features and predictors of the response to interferon
• Gender difference in alcoholic liver desease in Japan-an analysis based on histological findings
• Multiple primary neoplasms and hepatitis C virus infection in oral cancer patients
• A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
• Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
• Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
• GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
• Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
• Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
• Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
• Effect of Varying Polymerization Modes on Flexural Strength of an Indirect Composite Reinforced with a Monomer-Impregnated Glass Fiber Material
• Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
• Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy

もっと見る 閉じる

スポンサーリンク